U.S. District Judge Dabney L. Friedrich denied a Novartis Pharmaceuticals Corp. motion that would have blocked the U.S. Food and Drug Administration's regulatory approval of a generic heart failure medication based on Entresto, a lifesaving therapy developed by Novartis.
Biotech & Pharmaceuticals
August 14, 2024, 11:26 PM